16
Views
32
CrossRef citations to date
0
Altmetric
Cell Growth and Development

E2F Is Required To Prevent Inappropriate S-Phase Entry of Mammalian Cells

, , , , , , & show all
Pages 363-371 | Received 27 Jul 1999, Accepted 05 Oct 1999, Published online: 28 Mar 2023
 

Abstract

E2F is a family of transcription factors that regulates the cell cycle. It is widely accepted that E2F-mediated transactivation of a set of genes is the critical activity that governs cellular progression through G1 into S phase. In contrast to this hypothesis, we demonstrate that E2F actually suppresses the onset of S phase in two cell types when the cells are arrested by gamma irradiation. Our findings indicate that in these cells, the critical event triggering progression from G0/G1 arrest into S phase is the release of E2F-mediated transrepression of cell cycle genes, not transactivation by E2F. Furthermore, our data suggest that E2F-mediated transactivation is not necessary for the G1/S-phase transition in these cells.

ACKNOWLEDGMENTS

We thank Roger Watson and Peggy Farnham for gifts of the b-myb and DHFR plasmids and L. Carayannopoulos and N. Levy for review of the manuscript.

S.J.W. is supported in part by the NIH and the American Lung Association, and U.W. received support from the Deutscher Akademischer Austauschdienst.

S.H., B.L.C., B.E.D., and U.W. contributed equally to this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.